Rachil Remedies Profile
Key Indicators
- Authorised Capital ₹ 5.10 M
as on 24-10-2024
- Paid Up Capital ₹ 5.10 M
as on 24-10-2024
- Company Age 18 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.60 Cr
as on 24-10-2024
- Satisfied Charges ₹ 6.30 M
as on 24-10-2024
- Revenue -9.83%
(FY 2023)
- Profit 11.51%
(FY 2023)
- Ebitda -20.41%
(FY 2023)
- Net Worth 27.04%
(FY 2023)
- Total Assets -31.74%
(FY 2023)
About Rachil Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.10 M and a paid-up capital of Rs 5.10 M.
The company currently has active open charges totaling ₹1.60 Cr. The company has closed loans amounting to ₹6.30 M, as per Ministry of Corporate Affairs (MCA) records.
Ankur Agarwal, Manoj Jain, Pran Mehta, and Three other members serve as directors at the Company.
- CIN/LLPIN
U45202UP2006PTC090994
- Company No.
090994
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Feb 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Agra, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Rachil Remedies?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ankur Agarwal  | Director | 22-May-2014 | Current |
| Manoj Jain | Director | 13-Feb-2006 | Current |
| Pran Mehta | Director | 07-Mar-2009 | Current |
| Anshul Agarwal | Director | 01-Jun-2014 | Current |
| Anjul Agarwal | Director | 24-Jul-2014 | Current |
| Suchita Mittal | Director | 24-Jul-2014 | Current |
Financial Performance and Corporate Structure Insights of Rachil Remedies.
Rachil Remedies Pvt Ltd, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.83% decrease. The company also saw a substantial improvement in profitability, with a 11.51% increase in profit. The company's net worth Soared by an impressive increase of 27.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rachil Remedies?
In 2023, Rachil Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Meek Pharma Private LimitedActive 19 years 4 monthsAnkur Agarwal and Anshul Agarwal are mutual person
- Radhashok Pharmachem Private LimitedActive 8 years 7 months
Anshul Agarwal and Anjul Agarwal are mutual person
- Lumicon Solutions Private LimitedActive 6 years 1 month
Anjul Agarwal and Suchita Mittal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Dec 2016 | ₹1.00 M | Open |
Others Creation Date: 16 Dec 2016 | ₹1.50 Cr | Open |
Oriental Bank Of Commerce Creation Date: 11 Oct 2007 | ₹3.00 M | Satisfied |
How Many Employees Work at Rachil Remedies?
Rachil Remedies has a workforce of 21 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rachil Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rachil Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
